Last reviewed · How we verify
Nebivolol in Chronic Obstructive Pulmonary Disease
The purpose of this study is to demonstrate the safety and effectiveness of the study drug Nebivolol, in people who suffer with high blood pressure with Chronic Obstructive Pulmonary Disease (COPD).
Details
| Lead sponsor | University of Chicago |
|---|---|
| Phase | Phase 2/Phase 3 |
| Status | WITHDRAWN |
| Start date | 2012-01 |
| Completion | 2013-03 |
Conditions
- High Blood Pressure
Interventions
- Placebo
- Nebivolol
Primary outcomes
- to assess blood pressure control — baseline to 4 weeks
blood pressure control will be assessed per collection of research data at protocol visits.
Countries
United States